Got something to say about drugs? We’re always on the look out for unique angles and informed, nuanced insights into drug policy—and we pay for content. Politics, tech, medicine, case studies, opinion, policy, interviews get your drug story pitches to us.
ABOUT THE COMPANY
Volteface is an independent research and advocacy organisation that seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy reform. It cultivates fresh thinking and new ideas through its policy reports and online magazine.
We’re always open to pitches. We commission on a rolling basis. No deadline but obviously the sooner the better as we have a set monthly budget.
WHAT TO INCLUDE IN SUBMISSION
COMPENSATION
CONTACT
For more information, visit their website.
Email all questions and submissions to Katya Kowalski, Head of Operations at Volteface, at: katya@volteface.me
The Indianapolis Business Journal is looking for our next news editor, a role that focuses…
Axios has chosen Ben Berkowitz to be its next managing editor of business and markets.…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm thrilled…
Rest of World editor in chief Anup Kaphle sent out the following on Monday: We are excited…
The Financial Times has hired Veena Venugopal as its India newsletter editor. She has been working at…
Benjamin Parkin has been named Middle East and Africa news editor at the Financial Times, based…